Klotho Neurosciences (KLTO) Competitors $0.38 +0.01 (+2.51%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends KLTO vs. CLDI, OCX, UBX, IXHL, IBIO, BIVI, SRZN, RLYB, CVKD, and MRNSShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Calidi Biotherapeutics (CLDI), OncoCyte (OCX), Unity Biotechnology (UBX), Incannex Healthcare (IXHL), iBio (IBIO), BioVie (BIVI), Surrozen (SRZN), Rallybio (RLYB), Cadrenal Therapeutics (CVKD), and Marinus Pharmaceuticals (MRNS). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Calidi Biotherapeutics OncoCyte Unity Biotechnology Incannex Healthcare iBio BioVie Surrozen Rallybio Cadrenal Therapeutics Marinus Pharmaceuticals Klotho Neurosciences (NASDAQ:KLTO) and Calidi Biotherapeutics (NYSE:CLDI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation. Which has stronger valuation & earnings, KLTO or CLDI? Klotho Neurosciences has higher earnings, but lower revenue than Calidi Biotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKlotho NeurosciencesN/AN/A$1.35MN/AN/ACalidi Biotherapeutics$50K555.66-$29.22MN/AN/A Do insiders & institutionals believe in KLTO or CLDI? 20.1% of Klotho Neurosciences shares are held by institutional investors. Comparatively, 12.5% of Calidi Biotherapeutics shares are held by institutional investors. 2.0% of Klotho Neurosciences shares are held by insiders. Comparatively, 24.3% of Calidi Biotherapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer KLTO or CLDI? Klotho Neurosciences and Calidi Biotherapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformKlotho NeurosciencesN/AN/ACalidi BiotherapeuticsN/AN/A Does the media refer more to KLTO or CLDI? In the previous week, Klotho Neurosciences' average media sentiment score of 0.00 equaled Calidi Biotherapeutics'average media sentiment score. Company Overall Sentiment Klotho Neurosciences Neutral Calidi Biotherapeutics Neutral Do analysts rate KLTO or CLDI? Calidi Biotherapeutics has a consensus target price of $16.67, suggesting a potential upside of 1,487.30%. Given Calidi Biotherapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Calidi Biotherapeutics is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Calidi Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is KLTO or CLDI more profitable? Company Net Margins Return on Equity Return on Assets Klotho NeurosciencesN/A N/A -25.89% Calidi Biotherapeutics N/A N/A -344.45% SummaryCalidi Biotherapeutics beats Klotho Neurosciences on 5 of the 8 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.13M$3.11B$5.84B$9.15BDividend YieldN/A1.55%4.75%3.85%P/E RatioN/A27.4925.4719.00Price / SalesN/A329.47447.5876.30Price / Cash0.95168.8738.0134.83Price / Book-0.183.687.644.62Net Income$1.35M-$71.72M$3.18B$245.85M7 Day Performance-4.13%-2.50%-1.99%-2.68%1 Month Performance-13.04%-0.32%-0.42%-2.19%1 Year PerformanceN/A-12.32%16.51%12.84% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$0.38+2.5%N/AN/A$10.13MN/A0.00N/AGap UpCLDICalidi Biotherapeutics1.9905 of 5 stars$1.32+1.5%$16.67+1,162.6%N/A$34.93M$50,000.000.0038Gap UpOCXOncoCyte2.4408 of 5 stars$2.07+3.0%$4.42+113.4%-13.7%$34.84M$1.50M0.00120Gap UpUBXUnity Biotechnology3.8575 of 5 stars$2.04-4.7%$7.33+259.5%+10.9%$34.37M$240,000.00-1.5660Negative NewsIXHLIncannex Healthcare0.5417 of 5 stars$1.91-9.0%N/A-74.4%$33.69M$10,000.00-1.373Earnings ReportIBIOiBio0.7421 of 5 stars$3.42-8.1%$4.30+25.7%N/A$33.62M$220,000.000.00100News CoverageBIVIBioVie1.6241 of 5 stars$1.86-3.1%$3.00+61.3%+24.4%$33.05MN/A-0.1610SRZNSurrozen3.0124 of 5 stars$10.00-3.9%$38.50+285.0%-18.2%$32.50M$12.50M0.0080RLYBRallybio2.4536 of 5 stars$0.78-7.6%$9.75+1,150.0%-58.1%$32.36MN/A-0.4940High Trading VolumeCVKDCadrenal Therapeutics2.9025 of 5 stars$17.87-4.4%$32.00+79.1%N/A$31.81MN/A-2.684MRNSMarinus Pharmaceuticals4.2119 of 5 stars$0.55+0.1%$4.79+770.1%-94.4%$30.37M$31.47M-0.22110Analyst Forecast Related Companies and Tools Related Companies Calidi Biotherapeutics Competitors OncoCyte Competitors Unity Biotechnology Competitors Incannex Healthcare Competitors iBio Competitors BioVie Competitors Surrozen Competitors Rallybio Competitors Cadrenal Therapeutics Competitors Marinus Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KLTO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLTO Stock Alerts